Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer

NCT02028494 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Capecitabine

Sponsor

Latin American & Caribbean Society of Medical Oncology

Collaborators

[object Object]